Müller-Tiemann B F, Halazonetis T D, Elting J J
Institute for Bone and Joint Disorders and Cancer, Bayer Corporation, Pharmaceutical Division, 400 Morgan Lane, West Haven, CT 06516, USA.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6079-84. doi: 10.1073/pnas.95.11.6079.
The DNA binding activity of p53 is crucial for its tumor suppressor function and is subject to tight regulation. Previous studies revealed that the inhibitory function of the p53 C terminus is implicated in the latent, low affinity sequence-specific DNA binding activity of p53 in the uninduced state. Sequence-specific DNA binding of p53 has been shown to be activated by several posttranslational modifications and interacting proteins that target predominantly the C terminus. Moreover, several authors have shown that synthetic peptides corresponding to p53 C-terminal sequences activate p53 sequence-specific DNA binding. In an effort to identify the interaction site of p53 with these activating peptides we assessed complex formation between p53 deletion constructs and C-terminal activating peptides by peptide affinity precipitation. This study revealed that two distal regions of the p53 molecule contribute synergistically to the interaction with activating C-terminal peptides: amino acids 80-93 and 364-393. The C-terminal residues 364-393 are already well characterized as having negative regulatory function. DNA binding analyses with these deletion constructs reveal a comparable negative regulatory activity for residues 80-93, defining this region as a previously unidentified negative regulatory domain of p53. Furthermore, synthetic peptides spanning this newly identified proline-rich negative regulatory region (residues 80-93) are able to activate p53 sequence-specific DNA binding in vitro. We suggest that both negative regulatory regions, residues 80-93 and 364-393, contribute cooperatively to the maintenance of the latent, low-affinity DNA binding conformation of p53.
p53的DNA结合活性对其肿瘤抑制功能至关重要,且受到严格调控。先前的研究表明,p53 C末端的抑制功能与p53在未诱导状态下潜在的、低亲和力序列特异性DNA结合活性有关。p53的序列特异性DNA结合已被证明可被几种主要靶向C末端的翻译后修饰和相互作用蛋白激活。此外,几位作者表明,与p53 C末端序列对应的合成肽可激活p53序列特异性DNA结合。为了确定p53与这些激活肽的相互作用位点,我们通过肽亲和沉淀评估了p53缺失构建体与C末端激活肽之间的复合物形成。这项研究表明,p53分子的两个远端区域协同作用于与C末端激活肽的相互作用:氨基酸80 - 93和364 - 393。C末端残基364 - 393已被充分表征为具有负调控功能。对这些缺失构建体的DNA结合分析揭示了残基80 - 93具有类似的负调控活性,将该区域定义为p53一个先前未被识别的负调控结构域。此外,跨越这个新鉴定的富含脯氨酸的负调控区域(残基80 - 93)的合成肽能够在体外激活p53序列特异性DNA结合。我们认为,负调控区域残基80 - 93和364 - 393共同作用,维持p53潜在的、低亲和力DNA结合构象。